Spaventa Andrew

Chief Executive Officer at OMIC

Sold, on record
$37k
Dollars the filings state
Form 4 sales
4
Latest Feb 14, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • OMICSingular Genomics Systems, Inc.Chief Executive Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale OMICNo plan
    Sep 15, 2024 2024

    Sold 175 shares at $12.38 ($2k)

    Spaventa Andrew, Chief Executive Officer

    No 10b5-1 planSold 21.6% of holdings ($10k position)637 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale OMICUnusual
    Nov 12, 2024 +58 days

    Sold 695 shares at $22.55 ($16k)

    Spaventa Andrew, Chief Executive Officer

    No 10b5-1 planSold 31.1% of holdings ($50k position)1,537 shares leftFiling

  3. 3 Form 4 sale OMICNo plan
    Dec 16, 2024 +34 days

    Sold 180 shares at $20.16 ($4k)

    Spaventa Andrew, Chief Executive Officer

    No 10b5-1 planSold 22.2% of holdings ($16k position)631 shares leftFiling

  4. 4 Form 4 sale OMICUnusual
    Feb 14, 2025 +60 days

    Sold 800 shares at $19.89 ($16k)

    Spaventa Andrew, Chief Executive Officer

    No 10b5-1 planSold 35.8% of holdings ($44k position)1,432 shares left4.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Spaventa Andrew
Source
Feb 14, 2025Feb 14, 2025OMICChief Executive OfficerForm 4 sale800$16k35.8%UnusualSEC
Dec 16, 2024Dec 17, 2024OMICChief Executive OfficerForm 4 sale180$4k22.2%No planSEC
Nov 12, 2024Nov 13, 2024OMICChief Executive OfficerForm 4 sale695$16k31.1%UnusualSEC
Sep 15, 2024Sep 17, 2024OMICChief Executive OfficerForm 4 sale175$2k21.6%No planSEC